[HTML][HTML] Molnupiravir for treatment of adults with mild or moderate COVID-19: A systematic review and meta-analysis of randomised controlled trials
Y Gao, M Liu, Z Li, J Xu, J Zhang, J Tian - Clinical Microbiology and …, 2023 - Elsevier
Background The effects of molnupiravir in treating patients with non-severe COVID-19
remain uncertain. Objectives To evaluate the efficacy and safety of molnupiravir in adult …
remain uncertain. Objectives To evaluate the efficacy and safety of molnupiravir in adult …
Molnupiravir for treatment of adults with mild or moderate COVID-19: a systematic review and meta-analysis of randomised controlled trials
Y Gao, M Liu, Z Li, J Xu, J Zhang… - Clinical microbiology and … - pubmed.ncbi.nlm.nih.gov
Background The effects of molnupiravir in treating patients with non-severe COVID-19
remain uncertain. Objectives To evaluate the efficacy and safety of molnupiravir in adult …
remain uncertain. Objectives To evaluate the efficacy and safety of molnupiravir in adult …
Molnupiravir for treatment of adults with mild or moderate COVID-19: a systematic review and meta-analysis of randomized controlled trials.
Y Gao, M Liu, Z Li, J Xu, J Zhang, J Tian - 2023 - cabidigitallibrary.org
Background: The effects of molnupiravir in treating patients with non-severe COVID-19
remain uncertain. Objectives: To evaluate the efficacy and safety of molnupiravir in adult …
remain uncertain. Objectives: To evaluate the efficacy and safety of molnupiravir in adult …
Molnupiravir for treatment of adults with mild or moderate COVID-19: a systematic review and meta-analysis of randomized controlled trials
Y Gao, M Liu, Z Li, J Xu… - Clinical …, 2023 - clinicalmicrobiologyandinfection …
Background The effects of molnupiravir in treating patients with non-severe COVID-19
remain uncertain. Objectives To evaluate the efficacy and safety of molnupiravir in adult …
remain uncertain. Objectives To evaluate the efficacy and safety of molnupiravir in adult …
Molnupiravir for treatment of adults with mild or moderate COVID-19: a systematic review and meta-analysis of randomised controlled trials
Y Gao, M Liu, Z Li, J Xu, J Zhang… - Clinical Microbiology and …, 2023 - europepmc.org
Molnupiravir for treatment of adults with mild or moderate COVID-19: a systematic review and
meta-analysis of randomised controlled trials - Abstract - Europe PMC Sign in | Create an …
meta-analysis of randomised controlled trials - Abstract - Europe PMC Sign in | Create an …
[HTML][HTML] Molnupiravir for treatment of adults with mild or moderate COVID-19: a systematic review and meta-analysis of randomized controlled trials
Y Gao, M Liu, Z Li, J Xu, J Zhang, J Tian - Clinical Microbiology and … - ncbi.nlm.nih.gov
Molnupiravir for treatment of adults with mild or moderate COVID-19: a systematic review and
meta-analysis of randomized controlled trials - PMC Back to Top Skip to main content NIH NLM …
meta-analysis of randomized controlled trials - PMC Back to Top Skip to main content NIH NLM …
Molnupiravir for treatment of adults with mild or moderate COVID-19: a systematic review and meta-analysis of randomised controlled trials.
Y Gao, M Liu, Z Li, J Xu, J Zhang… - Clinical Microbiology and …, 2023 - europepmc.org
Molnupiravir for treatment of adults with mild or moderate COVID-19: a systematic review and
meta-analysis of randomised controlled trials. - Abstract - Europe PMC Sign in | Create an …
meta-analysis of randomised controlled trials. - Abstract - Europe PMC Sign in | Create an …